Amgen Foundation and Changemakers Launch Global Online Competition to Empower Patients

Amgen Inc.The Amgen Foundation is supporting an online competition with Ashoka's Changemakers to find the best solutions that elevate patients' voices to improve health outcomes globally.

The Patients | Choices | Empowerment competition is seeking solutions that tap the medical experience, knowledge, and wisdom of current and past patients, health care practitioners, advocates and other key stakeholders to ensure that patients have an active role in their personal healthcare. The ideal solutions are those that empower the patient and provide avenues for informed decisions.

"With healthcare a key concern around the globe, the Amgen Foundation hopes the competition will surface solutions that can give patients the knowledge and confidence to participate collaboratively at every stage of their healthcare," said Jean J. Lim, president of the Amgen Foundation.

The competition takes place at www.changemakers.com/empower-patient where visitors can enter the competition, discuss and share ideas related to patient empowerment, comment on entries, and vote for the finalists. Finalists will be selected by an expert panel of judges based on innovation, social impact, and sustainability. Three winners will each be awarded US$10,000. Entries will be accepted until Sept. 29, 2010 and the winners will be announced in December 2010.

"We look forward to seeing the global Changemakers community, including Ashoka's network of social entrepreneurs, collaborate to build a worldwide network of support for patients so they experience better health outcomes," said Sushmita Ghosh, founder and chair of Ashoka's Changemakers. "This competition will encourage participants to innovate and collaborate, form partnerships, and build a movement that empowers patients."

Following the Changemakers competition, selected entries may be invited to submit proposals to the Amgen Foundation for future funding consideration. The Amgen Foundation will consider awarding up to US$1 million in grants to support promising innovations in patient empowerment submitted by qualifying nonprofit organizations.

About Ashoka's Changemakers
Ashoka's Changemakers is a community of action that connects social entrepreneurs around the globe to share ideas, inspire, and mentor each other. Through its online collaborative competitions and open-source process, Changemakers.com is one of the world's most robust spaces for launching, discussing, and funding ideas to solve the world's most pressing social problems. Changemakers builds on Ashoka's three decade history and belief that we all have the ability to be a Changemaker.
www.Changemakers.com

About The Amgen Foundation
The Amgen Foundation (http://www.amgen.com/citizenship/overview.html) seeks to advance science education; improve patient access to quality care; and strengthen the communities where Amgen staff members live and work. Since 1991, the Foundation has made more than $140 million in grants to nonprofit organizations throughout the United States, Puerto Rico, and Europe that impact society in inspiring and innovative ways, and those that provide disaster relief efforts both domestically and internationally.

Most Popular Now

Primary endpoint met in COMET-TAIL Phase III trial…

GlaxoSmithKline plc (LSE/NYSE: GSK) and Vir Biotechnology, Inc. (Vir) (Nasdaq: VIR) announced headline data from the randomised, multi-centre, open-label COMET-TAIL Phase...

Merck and Ridgeback's molnupiravir, an oral COVID-…

Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics announced that the United Kingdom Medicines and Healthcare products Re...

Two billion doses of AstraZeneca’s COVID-19 vaccin…

AstraZeneca and its partners have released for supply two billion doses of their COVID-19 vaccine to more than 170 countries across every continent on the planet in the l...

Johnson & Johnson COVID-19 vaccine named one o…

The editors of Time announced that the Johnson & Johnson COVID-19 vaccine has been selected as one of Time's Best Inventions of 2021. The vaccine, for which Johnson & ...

New target for COVID-19 vaccines identified

Next generation vaccines for COVID-19 should aim to induce an immune response against 'replication proteins', essential for the very earliest stages of the viral cycle, c...

Safety concerns raised for neuroblastoma candidate…

St. Jude Children's Research Hospital scientists looking for drugs to improve survival of children with high-risk neuroblastoma found a promising candidate in CX-5461. Th...

Pfizer's novel COVID-19 oral antiviral treatment c…

Pfizer Inc. (NYSE: PFE) today announced its investigational novel COVID-19 oral antiviral candidate,PAXLOVID™, significantly reduced hospitalization and death, based on a...

Repurposing a familiar drug for COVID-19

For the past year and a half, the COVID-19 pandemic has continued to engulf the globe, fueled in part by novel variants and the uneven distribution of vaccines. Every day...

'Dancing molecules' successfully repair severe spi…

Northwestern University researchers have developed a new injectable therapy that harnesses “dancing molecules” to reverse paralysis and repair tissue after severe spinal ...

Researchers reveal a strategy for next-generation …

A study led by the Garvan Institute of Medical Research has revealed a guide to developing COVID-19 vaccines that both prevent the coronavirus from infecting human cells ...

A target for potential cancer drugs may, in fact, …

In recent years, much scientific effort and funding has focused on developing drugs that target an enzyme with the unwieldy name of Src homology 2-containing protein tyro...

A commonly found parasite could treat certain type…

Scientists have discovered that a deadly parasite, known to cause ill health in pregnant women and immunocompromised patients, could potentially be used to treat various ...